In Alzheimer’s disease rat model, up-regulation of lncRNA MEG3 can inhibit the activation of astrocytes in hippocampus in Alzheimer’s disease by inhibiting PI3K/Akt signaling pathway, alleviate neuronal damage, and improve cognitive impairment (Yi et al., 2019). This evidence concerns the gene MEG3 and early-onset autosomal dominant Alzheimer disease.